Table 2 Baseline characteristics per comorbidity cluster.

From: Comorbidity patterns and immune-metabolic differences in patients with acute-episode of schizophrenia spectrum disorders

Characteristics

Overall (n = 3697)

SSD comorbidity patterns

Statistical Value

P value

SSD only (n = 2880)

High-risk metabolic multisystem disorders cluster (n = 39)

Low-risk metabolic multisystem disorders cluster (n = 573)

Sleep disorders cluster (n = 205)

  

Gender

Female

1756 (47.50)

1342 (46.60)

21 (53.85)

273 (47.64)

120 (58.54)

11.59a

0.010*

Male

1941 (52.50)

1538 (53.40)

18 (46.15)

300 (52.36)

85 (41.46)

  

Marital status

Married

2296 (62.10)

1836 (63.75)

25 (64.10)

344 (60.03)

91 (44.39)

37.71a

<0.001*

Single

1117 (30.21)

827 (28.72)

8 (20.51)

188 (32.81)

94 (45.85)

  

Divorced/Widowed

284 (7.68)

217 (7.53)

6 (15.38)

41 (7.16)

20 (9.76)

  

Work status

Blue-Collar

3084 (83.42)

2428 (84.31)

31 (79.49)

453 (79.06)

172 (83.90)

b

<0.001*

White-Collar

264 (7.14)

201 (6.98)

4 (10.26)

47 (8.20)

12 (5.85)

  

Unemployed

244 (6.60)

178 (6.18)

2 (5.13)

47 (8.20)

17 (8.29)

  

Retired

105 (2.84)

73 (2.53)

2 (5.13)

26 (4.54)

4 (1.95)

  

Age group

≤25

469 (12.69)

375 (13.02)

1 (2.56)

59 (10.30)

34 (16.59)

b

<0.001*

26–39

1142 (30.89)

901 (31.28)

3 (7.69)

167 (29.14)

71 (34.63)

  

40–59

1753 (47.42)

1365 (47.40)

17 (43.59)

280 (48.87)

91 (44.39)

  

≥60

333 (9.01)

239 (8.30)

18 (46.15)

67 (11.69)

9 (4.39)

  

Ethnic group

Minority

696 (18.83)

571 (19.83)

7 (17.95)

98 (17.10)

20 (9.76)

14.05a

0.006*

Han

3001 (81.17)

2309 (80.17)

32 (82.05)

475 (82.90)

185 (90.24)

  

Educational

Primary and below

1959 (52.99)

1552 (53.89)

10 (25.64)

294 (51.31)

103 (50.24)

b

 

Secondary School

1493 (40.38)

1140 (39.58)

25 (64.10)

239 (41.71)

89 (43.41)

 

<0.001*

Higher Education

245 (6.63)

188 (6.53)

4 (10.26)

40 (6.98)

13 (6.34)

  

Payment

Rural Residents (Insurance)

902 (24.40)

901 (31.28)

0 (0)

1 (0.17)

0 (0)

b

<0.001*

Urban And Rural Residents (Insurance)

2711 (73.33)

1907 (66.22)

38 (97.44)

566 (98.78)

200 (97.56)

  

Self-Pay

84 (2.27)

72 (2.50)

1 (2.56)

6 (1.05)

5 (2.44)

  

Admission count

1

1852 (50.09)

1485 (51.56)

17 (43.59)

249 (43.46)

101 (49.27)

18.62a

0.003*

1–2

1110 (30.02)

856 (29.72)

15 (38.46)

183 (31.94)

56 (27.32)

  

≥3

735 (19.88)

539 (18.72)

7 (17.95)

141 (24.61)

48 (23.41)

  

Length of hospital stay, day

53.00 (28.00, 64.00)

54.00 (29.00, 63.00)

50.00 (26.50, 54.00)

51.00 (28.00, 65.00)

53.00 (29.00, 76.00)

4.50c

0.092

Blood groups

AB

317 (8.57)

248 (8.61)

3 (7.69)

47 (8.20)

19 (9.27)

b

<0.001*

A

1073 (29.02)

864 (30.00)

4 (10.26)

140 (24.43)

65 (31.71)

  

B

809 (21.88)

652 (22.64)

5 (12.82)

116 (20.24)

36 (17.56)

  

O

987 (26.70)

770 (26.74)

4 (10.26)

142 (24.78)

71 (34.63)

  

Unknown

511 (13.82)

346 (12.01)

23 (58.97)

128 (22.34)

14 (6.83)

  

Lipid metabolism metrics

Total cholesterol, mmol/L

4.25 (3.63, 4.95)

4.22 (3.63, 4.96)

4.28 (3.54, 4.95)

4.32 (3.68, 4.93)

4.18 (3.60, 4.90)

1.30c

0.728

Triglyceride, mmol/L

1.24 (0.90, 1.84)

1.25 (0.89, 1.86)

1.03 (0.81, 1.71)

1.27 (0.92, 1.83)

1.12 (0.85, 1.54)

7.59c

0.055

High-density lipoprotein cholesterol, mmol/L

1.14 (0.94, 1.35)

1.14 (0.92, 1.36)

1.17 ± 0.28

1.14 (0.97, 1.33)

1.11 (0.94, 1.36)

0.24c

0.972

Low Density lipoprotein cholesterol, mmol/L

2.57 (2.10, 3.15)

2.51 (2.04, 3.14)

2.85 (2.42, 3.25)

2.70 (2.16, 3.20)

2.52 (2.09, 3.07)

16.16c

0.001*

Free Fatty Acids, mmol/L

0.36 (0.26, 0.60)

0.35 (0.26, 0.62)

0.36 (0.24, 0.62)

0.36 (0.26, 0.60)

0.35 (0.25, 0.54)

1.58c

0.664

Apolipoprotein AI, g/L

1.28 (1.13, 1.49)

1.28 (1.12, 1.51)

1.22 ± 0.21

1.28 (1.13, 1.47)

1.36 (1.17, 1.50)

9.14c

0.028*

Apolipoprotein B, g/L

0.72 (0.61, 0.84)

0.73 (0.64, 0.82)

0.86 (0.69, 1.04)

0.72 (0.60, 0.88)

0.67 (0.51, 0.78)

19.60c

<0.001*

Apolipoprotein A, mg/L

11.75 (4.77, 37.52)

10.15 (4.20, 28.45)

52.80 (35.60, 141.00)

14.00 (5.40, 47.70)

10.15 (4.38, 30.40)

41.40c

<0.001*

Systemic inflammation metrics

Red blood cell, 1012/L

4.71 (4.37, 5.06)

4.68 (4.35, 5.03)

4.75 ± 0.57

4.75 (4.38, 5.09)

4.85 ± 0.60

10.25c

0.017*

Hemoglobin, g/L

141.00 (131.00, 154.00)

141.00 (130.00, 154.00)

142.59 ± 16.00

142.00 (132.00, 154.00)

146.20 ± 16.96

12.33c

0.006*

Hematocrit, %

42.00 (39.00, 46.00)

42.00 (39.00, 46.00)

0.43 (0.40, 0.49)

41.00 (6.17, 45.00)

44.00 (41.00, 47.00)

112.58c

<0.001*

Mean corpuscular volume, fl

90.70 (87.80, 93.70)

90.70 (87.90, 93.70)

89.91 ± 4.63

90.60 (87.60, 93.90)

90.65 (87.70, 93.82)

1.59c

0.661

Mean Corpuscular Hemoglobin, pg

30.30 (29.20, 31.50)

30.30 (29.10, 31.40)

30.16 ± 2.24

30.30 (29.20, 31.50)

30.55 (29.40, 31.80)

2.10c

0.551

Mean corpuscular hemoglobin concentration, g/L

333.00 (328.00, 340.00)

333.00 (327.00, 339.00)

335.14 ± 12.15

334.00 (328.00, 340.00)

334.97 ± 9.47

7.94c

0.047*

Red Cell Distribution Width Coefficient of Variation, %

11.70 (11.20, 12.40)

11.70 (11.20, 12.20)

13.15 ± 0.82

12.00 (11.50, 12.80)

11.60 (11.10, 11.93)

107.03c

<0.001*

Platelet, 109/L

219.00 (181.00, 263.00)

218.00 (177.00, 262.00)

219.27 ± 47.67

219.00 (185.00, 267.00)

224.98 ± 64.67

1.32c

0.724

Platelet distribution width, fl

17.00 (16.30, 17.60)

17.20 (16.60, 17.80)

12.80 ± 2.48

16.70 (12.80, 17.40)

17.15 (16.70, 17.60)

136.13c

<0.001*

Mean platelet volume, fl

9.50 (8.40, 10.60)

9.40 (8.30, 10.50)

10.41 ± 1.28

9.70 (8.70, 10.80)

9.00 (8.07, 10.30)

31.87c

<0.001*

Plateletcrit, %

0.20 (0.17, 0.24)

0.20 (0.17, 0.24)

0.23 ± 0.05

0.21 (0.18, 0.25)

0.20 (0.16, 0.23)

21.22c

<0.001*

Red Cell Distribution Width - Standard Deviation, fl

42.60 (40.40, 45.10)

42.50 (40.30, 45.00)

43.52 ± 3.09

42.60 (40.25, 45.12)

41.50 ± 3.04

1.99c

0.575

Platelet-larger cell ratio, %

27.75 (21.33, 33.18)

27.70 (20.90, 33.10)

29.69 ± 8.10

27.50 (21.45, 33.10)

24.77 ± 3.25

2.38c

0.497

white blood cell, 109/L

6.40 (5.30, 7.70)

6.30 (5.20, 7.60)

6.57 ± 1.81

6.50 (5.40, 7.96)

6.80 (5.70, 8.22)

18.03c

<0.001*

Neutrophil percentage, %

65.15 ± 10.18

65.22 ± 10.02

61.18 ± 11.81

64.24 ± 10.52

68.02 ± 9.36

7.78 d

<0.001*

Lymphocyte percentage, %

25.80 (19.80, 32.15)

25.70 (19.90, 32.50)

28.74 ± 10.45

26.95 ± 9.42

23.80 ± 8.44

15.10c

0.002*

Monocytes percentage, %

6.80 (5.70, 8.00)

6.80 (5.70, 8.00)

7.26 ± 1.67

6.90 (5.80, 8.10)

6.90 (5.70, 7.93)

1.32c

0.724

Eosinophil percentage, %

1.00 (0.55, 1.70)

1.00 (0.60, 1.60)

2.00 (0.70, 3.00)

1.00 (0.50, 1.90)

0.80 (0.40, 1.25)

20.72c

<0.001*

Basophil percentage, %

0.20 (0.20, 0.30)

0.20 (0.10, 0.30)

0.50 (0.30, 0.70)

0.20 (0.20, 0.40)

0.20 (0.10, 0.20)

78.70c

<0.001*

Absolute neutrophil count, 109/L

4.10 (3.20, 5.30)

4.00 (3.19, 5.20)

4.05 ± 1.45

4.10 (3.17, 5.50)

4.50 (3.68, 5.80)

18.32c

<0.001*

Absolute lymphocytes count, 109/L

1.60 (1.22, 2.06)

1.60 (1.20, 2.00)

1.80 (1.30, 2.29)

1.70 (1.30, 2.17)

1.60 (1.20, 1.90)

19.05c

<0.001*

Absolute monocyte count, 109/l

0.40 (0.34, 0.52)

0.40 (0.30, 0.50)

0.48 ± 0.17

0.43 (0.38, 0.57)

0.50 (0.40, 0.60)

11.32c

0.010*

Absolute eosinophil count, 109/L

0.10 (0.00, 0.10)

0.10 (0.00, 0.10)

0.10 (0.03, 0.19)

0.10 (0.00, 0.10)

0.10 (0.00, 0.10)

22.09c

<0.001*

Absolute basophil count, 109/L

0.00 (0.00, 0.00)

0.00 (0.00, 0.00)

0.03 (0.02, 0.05)

0.00 (0.00, 0.03)

0.00 (0.00, 0.00)

248.67c

<0.001*

Antistreptolysin O, IU/ml

55.20 (32.60, 101.90)

56.10 (35.20, 98.88)

369.80(245.45, 494.15)

51.15 (29.98, 113.45)

51.00 (25.90, 110.70)

6.02c

0.111

Rheumatoid factor, IU/ml

5.00 (3.00, 8.00)

5.00 (3.00, 8.00)

0.80(0.50, 1.10)

4.40 (2.80, 8.00)

4.00 (2.70, 7.00)

11.45c

0.010*

C-reactive protein, mg/L

1.60 (0.60, 3.50)

1.90 (0.88, 3.90)

2.15 (1.80, 4.67)

1.50 (0.52, 3.30)

1.30 (0.60, 2.80)

5.15c

0.161

Serum amyloid A, mg/L

5.20 (3.10, 8.95)

6.10 (4.38, 12.63)

9.81 ± 11.57

4.90 (3.02, 9.25)

3.90 (2.95, 6.80)

8.89c

0.031*

Monocyte to high-density lipoprotein cholesterol ratio

0.40 (0.29, 0.54)

0.40 (0.29, 0.54)

0.49 ± 0.22

0.38 (0.28, 0.51)

0.43 (0.36, 0.59)

6.42c

0.093

Monocyte-to-lymphocyte ratio

0.27 (0.21, 0.36)

0.27 (0.21, 0.36)

0.28 (0.21, 0.33)

0.26 (0.20, 0.34)

0.30 (0.23, 0.39)

11.23c

0.011*

Platelet-to-lymphocyte ratio

133.82 (101.57, 178.89)

135.62 (102.00, 183.12)

125.61 (95.44, 162.77)

129.22 (98.19, 166.92)

136.34 (107.06, 189.39)

9.54c

0.023*

Neutrophil-to-lymphocyte ratio

2.56 (1.81, 3.64)

2.56 (1.81, 3.62)

2.07 (1.60, 3.61)

2.46 (1.74, 3.44)

2.92 (2.07, 4.39)

18.11c

<0.001*

Systemic immune-inflammation index

547.08 (369.26, 835.27)

548.84 (365.22, 814.27)

481.96 (343.45, 746.26)

529.71 (353.11, 810.14)

611.08 (434.84, 1003.79)

13.03c

0.005*

System inflammation response index

1.11 (0.73, 1.73)

1.10 (0.72, 1.69)

1.08 (0.74, 1.45)

1.07 (0.71, 1.74)

1.26 (0.89, 2.10)

16.30c

<0.001*

Aggregate index of systemic inflammation

239.50 (150.18, 397.53)

234.65 (148.37, 386.26)

249.38 (162.33, 331.15)

233.39 (140.18, 399.84)

281.19 (184.49, 471.69)

12.55c

0.006*

Derived neutrophil to lymphocyte ratio

1.91 (1.41, 2.62)

1.90 (1.42, 2.62)

1.52 (1.26, 2.46)

1.88 (1.35, 2.47)

2.14 (1.61, 3.07)

19.50c

<0.001*

  1. aChi-squared test; bFisher’s exact test; cKruskal–Wallis; dANOVA; *P value <0.05.